Daiichi Sankyo Company Community
TSE:4568 Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 12 Fair Values set on narratives written by author
Community Investing Ideas
AN
Consensus Narrative from 18 Analysts
Our Oncology Portfolio Will Open New Treatment Markets
Key Takeaways Expanding oncology portfolio and strategic U.S. partnership are driving revenue growth by accessing new markets and indications. Increased R&D and production investments aim to improve operational efficiencies and boost net margins.
View narrativeJP¥5.94k
FV
39.4% undervalued intrinsic discount11.84%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
7 days ago author updated this narrative